Normoftal
Retina Cytogen · Ocular Cytogen · Normoftal peptide · Нормофтал
Normoftal is the retina cytogen on the NPCRIZ list. Our old card tagged it as a Cytomax extract (empty vial). Class is cytogen; Visoluten is the eye complex; Retinalamin is the pharmaceutical extract used in CIS ophthalmology.
Use-case scores
0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.
- Longevity / aging3.5/10
Khavinson-school tissue peptide. Single-lab concentration after haircut. Not a Western Phase 3 geroprotector.
- Cognition3.5/10
Nervous/pineal/visual aisle in the school. Not a stroke or dementia label.
Compound card
- Sequence
- Confirm COA (retina cytogen; not Retinalamin extract)
- Class
- Khavinson cytogen (retina)
- Formula
- Retina cytogen (not KE - KE is Vilon)
- Status
- Not FDA-approved · research use
How it works
Normoftal is the retina cytogen on the NPCRIZ list. It is not Lys-Glu - that dipeptide is Vilon (thymus). Visoluten is the eye Cytomax complex. Retinalamin is the pharmaceutical extract. Sequence is not as publicly standardized in English as AEDG or KED.
This is not anti-VEGF and not AREDS2. Degenerative retina disease still belongs to an ophthalmologist.
Source: PMID: 15677927
Khavinson map
Canonical 41Used in bioregulator stacks
Manufacturer-style organ combinations - not FDA protocols. Every name is a live leaf.
The Khavinson school
Vladimir Khatskelevich Khavinson (1946–2024) spent five decades at what became the St. Petersburg Institute of Bioregulation and Gerontology arguing a simple, stubborn idea: aging is, in part, a failure of tissue-specific peptide signals, and those signals can be restored. The first products were not “peptides” in the Instagram sense. They were Cytamins - polypeptide fractions isolated from a named organ of young animals. Later commercial refinements of those fractions are sold as Cytomaxes (Cytomed / NPCRIZ): still mixtures, still oral capsules, still defined by the source organ rather than a single sequence. When the group identified short active motifs inside those mixtures, they synthesized them as Cytogens - di-, tri-, and tetrapeptides with a one-letter code (KE, AEDG, KED, EDR, KEDP, and so on).
That three-layer stack is the whole map. Cytamin / pharmaceutical extracts (Thymalin, Epithalamin, Cortexin, Retinalamin, Prostatilen) are the clinic-era injectables registered in the former Soviet pharmacopeia. Cytomaxes are the capsule complexes Cytomed still lists as a 21-SKU organ line. Cytogens are the defined synthetics. English-language educators, including Brenden Henry’s public writing at Peptide Science Institute, add a further commercial distinction - later analog SKUs (N-acetyl, amidate, “V2” complexes) sold as more stable or more diverse than the original Cytomed lots. That last layer is a product taxonomy, not a Khavinson paper. We describe it so readers are not gaslit by three bottles with the same organ name. We do not reproduce paid Peptide Mastery protocols, Precision Cell Method language, or anyone else’s course IP.
Full Cytamin → Cytomax → Cytogen map, literature limits, and how we counted 41
The mechanism Khavinson published is epigenetic, not receptor-agonist in the GLP-1 sense. Short peptides are claimed to enter nuclei, interact with DNA/histones, and reopen tissue-specific transcription that condensed with age (heterochromatin → euchromatin). Reviews in the Bulletin of Experimental Biology and Medicine and Neuroendocrinology Letters (PMID 14523363, 15677927, 23888677) are the citable core. Complementary GI pharmacology is not mystical: di- and tripeptides are PEPT1/LAT substrates, which is why oral capsules are even a conversation. What is not established in Western Phase 3 programs is organ-by-organ disease treatment, telomere reversal as a clinical endpoint, or the manufacturer claim that Cytomax is “a third stronger” than Cytogen. Those are NPCRIZ marketing sentences.
Khavinson’s group published hundreds of papers, many in Russian, many in the same journal family. That is a real literature. It is also a literature with limited independent Western replication, small n, and a habit of using one review PMID as a stamp on every organ. On this site a leaf earns its organ story, its Cytomax↔Cytogen pair, its sequence if it has one, and an honest sentence about what has not been shown. Reconstitution math belongs on cytogens sold as vials. Cytomax capsules do not get a fake 5 mg vial.
The 41 we treat as canonical are the 21 Cytomaxes on the public e-peptide/Cytomed list, the 12 Cytogens on that same commercial line (including Vesilut, which Western catalogs often drop), plus eight historically load-bearing molecules that sit beside the capsule SKUs: Epitalon, Vilon, Thymogen, Livagen, Cortagen, Prostamax, Thymalin, and Epithalamin. Honluten, Cortexin, Retinalamin, Prostatilen, Thymulin, N-acetyl-epitalon-amidate, Pinalex, and the GPL Man / GPL Femme kits are covered as adjacent - same school or same storefront, not padded into a fake 41.
Public English-language teaching (including Brenden Henry at peptidescienceinstitute.com) is cited as context, not copied. Paid Peptide Mastery / Peptide Salvation text stays theirs.
History of this molecule
Three eye products, three classes - same as pineal and prostate. Retinalamin is the hospital extract (including parabulbar use in CIS practice). Visoluten is the oral Cytomax complex. Normoftal is the synthetic on the cytogen poster. Sequence is not as publicly standardized in English as AEDG or KED; we do not invent a tetrapeptide for the meta description.
This is not anti-VEGF. This is not AREDS2. Degenerative retina disease still belongs to an ophthalmologist.
Caveats
A defined sequence is not an FDA indication. Retina cytogens sit in a Russian experimental-gerontology literature with limited Western replication. “Oral bioavailability because PEPT1” is real peptide-transport biology; it is not proof this SKU treats the organ disease. Gray-market identity is a live problem - HPLC is the only way to know the vial is the sequence on the label.
Full 41-map: Khavinson bioregulators index · Bioregulator stacks
Research Use Cases
- ✓Visual health (research)
- ✓Retinal tissue in the Khavinson map
- ✓Pair with Visoluten as complex vs cytogen
Dosing
| Phase | Dose | Frequency | Notes |
|---|---|---|---|
| Khavinson Protocol | 1–2 capsules/day or 1–2 mg SC | Daily for 10–30 day courses, 1-2x per year | Retinal bioregulator. Often paired with Visoluten (eye extract) for comprehensive vision support. |
Administration
Normoftal: oral vs SubQ
- Official Cytomed cytogen SKU is a swallowed capsule. No BAC water, no syringe.
- Matches how Cytomed ships the poster line.
- Nobody manufactures this as a sublingual tablet.
- Official Cytomed Normoftal is a cytogen capsule. Our old empty-vial tag was a class bug, now corrected.
- Capsule milligrams are not 1–2 mg SC. Do not convert a research-vial protocol into capsule counts by arithmetic theater.
- Empty-stomach timing is user-guide folklore plus PEPT1 logic, not a cited human PK study for this SKU.
- Normoftal is the retina cytogen. It is not Visoluten, not Retinalamin, and not a Cytomax extract. Do not steal Vilon’s KE code for the meta description.
- Not anti-VEGF. Not AREDS2. Degenerative retina disease still belongs to an ophthalmologist.
- Vial math is checkable if the COA matches the sequence on the label.
- Food timing is irrelevant for SubQ.
- Short pulsed courses match how the school used defined synthetics.
- Gray-market identity: HPLC is the only way to know the cake is short retina cytogen (English residue string not standardized like AEDG or KED).
- Not a Western Phase 3. Russian experimental-gerontology literature is real and concentrated.
- Not a sublingual tablet and not a Cytomax complex.
- Normoftal is the retina cytogen. It is not Visoluten, not Retinalamin, and not a Cytomax extract. Do not steal Vilon’s KE code for the meta description.
- Do not inject in or near the eye. Retinalamin parabulbar use is a CIS pharmaceutical practice, not a DIY cytogen protocol.
Timeline
Who it is for
Ocular Health / Retinopathy
LowVision bioregulator. Counterpart to the Cytomax Visoluten.
Reconstitution
| Vial | Water | Concentration | Example dose |
|---|---|---|---|
| Lyophilized cytogen (if the SKU is a vial) | Follow the COA fill | Do the math | Capsules skip this step. Cytomax complexes are not this molecule. |
Change vial size or water volume? Open the reconstitution calculator.
Safety & Considerations
Research peptide. Extensively used in Russian clinical protocols. Russian clinic history is not a US safety NDA.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Limits of current evidence
- A defined sequence is not an FDA indication.
- Gray-market identity is a live problem. HPLC beats a blog table.
- Do not paste a sibling cytogen’s papers onto this SKU.
- This site will not treat the named organ disease from a peptide page.
Verdict
Normoftal is the synthetic short peptide cytogen for Retina. Khavinson’s group published in this family. That is a concentrated literature, not a Western Phase 3. Capsules and vials are different SKUs.
Interactions & Contraindications
Cytogen capsules or research vials - not a Cytomax extract protocol. Not anti-VEGF.
Synergies & Common Stacks
Normoftal is the cytogen; Visoluten is the Cytomax complex. Same organ, two classes. Retinalamin is the pharma extract.
Frequently Asked Questions
Normoftal vs Visoluten vs Retinalamin?▼
Was this a Cytomax on your site?▼
Macular degeneration treatment?▼
Inject in the eye?▼
Oral capsule or injection?▼
What is Normoftal used for?▼
References
- Khavinson VKh, Anisimov VN “Peptide bioregulators: a new class of geroprotectors. Message 1: results of experimental studies.” Bulletin of Experimental Biology and Medicine (2000). PMID: 11182816
- Khavinson VKh et al. “Tissue-specific effects of peptides.” Bulletin of Experimental Biology and Medicine (2005). PMID: 15677927
- Khavinson VKh, Lin’kova NS, Tarnovskaya SI “Short peptides regulate gene expression.” Bulletin of Experimental Biology and Medicine (2013). PMID: 23888677
- Khavinson VKh, Morozov VG “Peptide regulation of aging: from experimental studies to clinical practice.” Advances in Gerontology (2003). PMID: 14523363
📚 Related Articles
Get Normoftal from Vita-Stream - a distributor for Khavinson-line oral capsules. No reconstitution math on a Cytomax bottle.
Affiliate link · Full review